Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Teva and Lonza Announce Strategic Partnership to Become a Leading Global Provider of Biosimilars
- JERUSALEM & BASEL, Switzerland -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Lonza Group Ltd. (SIX: LONN) today announced their agreement to establish a joint venture to develop, manufacture and market a portfolio of biosimilars. Through this joint venture, Lonza and Teva bring together highly complementary capabilities that will significantly...
- Research articles 2009-01-20
- Bentley Pharmaceuticals Notifies NYSE of Intention to Delist Common Stock
- EXETER, N.H. -- Bentley Pharmaceuticals, Inc. (NYSE: BNT) ("Bentley" or the "Company") announced today that it notified the New York Stock Exchange (the "NYSE") of its intent to delist its common stock, par value $0.02 per share, from the NYSE immediately following the consummation of the transactions contemplated by the...
- Research articles 2008-07-08
- Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per Share
- EXETER, N.H. -- Bentley Pharmaceuticals, Inc. ("Bentley") (NYSE: BNT) announced that the aggregate cash purchase price for its acquisition by Teva Pharmaceutical Industries Ltd. ("Teva") has been adjusted in accordance with the merger agreement after completion of the previously announced taxable spin-off of its drug delivery business, CPEX Pharmaceuticals, Inc....
- Research articles 2008-07-03
- Teva to Present at the Piper Jaffray Third Annual Europe Conference
- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Piper Jaffray Third Annual Europe Conference in London. Dan Suesskind, Chief Financial Officer, will present on Wednesday, June 25, 2008. What: Teva Presentation at the Piper Jaffray Third Annual Europe Conference in London....
- Research articles 2008-06-24
- Teva to Acquire Bentley Pharmaceuticals
- Acquisition Will Provide Teva with a Strong Platform to Become a Leading Player in Spain JERUSALEM & EXETER, N.H. -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Bentley Pharmaceuticals, Inc. (NYSE: BNT) announced today that they have entered into a definitive agreement under which Teva will acquire Bentley. The...
- Research articles 2008-03-31
- Teva Reports 2007 Financials in XBRL Standard
- Intended to Facilitate Investors' Analysis of Results JERUSALEM -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today the filing of its 2007 income statement, balance sheet, cash flow statement and statement of changes in shareholders' equity, included in its 2007 Form 20-F previously filed with the SEC on February...
- Research articles 2008-03-25
- Teva Invites Public to Listen to Investor Day Webcast
- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast of its Investor Day on Thursday, February 21, 2008, from 9:00 a.m. till 12:30 p.m. ET. What: Teva's Strategy Overview Who: Teva Management When: Thursday, February 21, 2008 from 9:00 a.m. till 12:30...
- Research articles 2008-02-19
- Teva is The Clear Market Leader Since Its 2006 Purchase of IVAX States New Report Opportunities and Challenges for Generic Drugs In The UK 2007.
- M2 PRESSWIRE-2 July 2007-Research and Markets: Teva is The Clear Market Leader Since Its 2006 Purchase of IVAX States New Report Opportunities and Challenges for Generic Drugs In The UK 2007C1994-2007 M2 COMMUNICATIONS LTD RDATE:04072007 Dublin - Research and Markets ...
- Research articles 2007-07-02
- Stocks to Watch - ECLP, VZ, TISA, TEVA.
- M2 PRESSWIRE-20 September 2006-SmallCapReview: Stocks to Watch - ECLP, VZ, TISA, TEVAC1994-2006 M2 COMMUNICATIONS LTD RDATE:20092006 SmallCapReview Stocks to Watch for today include - Eclipsys Corporation (Nasdaq: ECLP), Verizon Business (NYSE: VZ), Top Image Systems (Nasdaq: TISA), Teva Pharmaceutical Industries (Nasdaq:...
- Research articles 2006-09-20
- Teva Announces Settlement of OxyContin® Litigation
- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has signed an agreement with The Purdue Frederick Company and certain of its affiliates to settle patent infringement litigation pertaining to Teva's generic version of Purdue's OxyContinR (oxycodone HCl extended-release) Tablets pending in the United States District Court...
- Research articles 2006-08-29
- Teva Launches Generic Zoloft.
- M2 PRESSWIRE-15 August 2006-InvestSource Inc.: Teva Launches Generic ZoloftC1994-2006 M2 COMMUNICATIONS LTD RDATE:15082006 Stocks in the News: Auriga LaboratoriesTM, Inc. (OTC: ARGA), Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), Gilead Sciences Inc. (NASDAQ: GILD), GlaxoSmithKline PLC (NYSE: GSK) For...
- Research articles 2006-08-15
- Market Gainer Updates Shareholders Of Teva Pharmaceutical Industries Ltd.
- M2 PRESSWIRE-1 May 2006-marketgainer.com: Market Gainer Updates Shareholders Of Teva Pharmaceutical Industries Ltd.C1994-2006 M2 COMMUNICATIONS LTD RDATE:01052006 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets....
- Research articles 2006-05-01
- Teva Announces FTC Will Not File Objections to Effexor® XR Settlement
- JERUSALEM -- The Federal Trade Commission has notified Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Wyeth (NYSE:WYE) that it will not file an objection with the United States District Court for the District of New Jersey to the proposed settlement of the patent litigation between Teva and Wyeth concerning Teva's...
- Research articles 2005-12-02
- WATER SPORTS; FOR SPRING '06, DESIGNERS ARE OFFERING UP ATHLETIC-INSPIRED OUTDOOR STYLES BUILT TO ENDURE WET ENVIRONMENTS. FROM MUDDY TRAILS TO WHITE-WATER RAPIDS, THE NEWEST AMPHIBIOUS FOOTWEAR MODELS FEATURE WATER-FRIENDLY MESH PANELS, DRAINAGE PORTS, F
- Helly Hansen's Hydrator W2 Breathe features perforations in the upper, midsole and outsole for quick water release. Waterra ST trail-running sandal from Adidas features drainage system. Water-friendly Devil Ray slip-on from Ecco. Rogue River from Hi-Tec...
- Research articles 2005-10-03
- Geron Corporation reports 2005 second quarter financial results and events and Stephen G. Sudovar elected to Aastrom Biosciences' Board of Directors.
- M2 PRESSWIRE-8 August 2005-US Financial Network: Geron Corporation reports 2005 second quarter financial results and events and Stephen G. Sudovar elected to Aastrom Biosciences' Board of DirectorsC1994-2005 M2 COMMUNICATIONS LTD RDATE:08082005 City of Industry, CA - Biotechnology industry news provided by...
- Research articles 2005-08-08
- July 26th Stock Trading Alert
- eLocity's stocks to watch for Tuesday are -- GeneThera (OTC BB: GTHA), LifeCell Corp. (NASDAQ: LIFC), Teva Pharmaceutical (NASDAQ: TEVA), DNAPrint genomics, Inc. (OTC BB: DNAG) Investors, have a look at GeneThera (OTC BB: GTHA), a molecular biotechnology company that currently provides genetic diagnostic solutions for the veterinary and...
- Research articles 2005-07-26
- Teva to acquire Ivax and LifeCell Corporation announces Q2 financial results.
- M2 PRESSWIRE-25 July 2005-US Financial Network: Teva to acquire Ivax and LifeCell Corporation announces Q2 financial resultsC1994-2005 M2 COMMUNICATIONS LTD RDATE:25072005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). LifeCell Corporation (Nasdaq: LIFC) ...
- Research articles 2005-07-25
- Teva Pharm announces tentative approval of Fexofenadine HCl Tablets: PYPR, TEVA, AMAC, NSTC.
- M2 PRESSWIRE-21 July 2005-InvestSource Inc.: Teva Pharm announces tentative approval of Fexofenadine HCl Tablets: PYPR, TEVA, AMAC, NSTCC1994-2005 M2 COMMUNICATIONS LTD RDATE:21072005 Stocks in the News: Paypro Incorporated (Other OTC: PYPR), Teva Pharmaceuticals Industries Limited (NASDAQ: TEVA), American Medical Alert...
- Research articles 2005-07-21
- TEVA announces approval of Clarithromycin ER tablets, Pharmion Corporation to present at UBS Global Pharmaceuticals Conference.
- M2 PRESSWIRE-19 May 2005-US Financial Network: TEVA announces approval of Clarithromycin ER tablets, Pharmion Corporation to present at UBS Global Pharmaceuticals ConferenceC1994-2005 M2 COMMUNICATIONS LTD RDATE:19052005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC:...
- Research articles 2005-05-19
- InvestSource: Biopharmaceutical Companies Soar in the Market: CEPO, CRXA, ELN, COR, TEVA.
- M2 PRESSWIRE-3 May 2005-InvestSource Inc.: InvestSource: Biopharmaceutical Companies Soar in the Market: CEPO, CRXA, ELN, COR, TEVAC1994-2005 M2 COMMUNICATIONS LTD RDATE:03052005 Stocks in the News: Ceptor Corporation (OTCBB:CEPO), Corxia Corporation (NASDAQ: CRXA), Elan Pharmaceuticals (NYSE: ELN), Cortex Pharmaceuticals Incorporated (AMEX:...
- Research articles 2005-05-03
- << Previous
- page 1 of 3
- Next >>
Refining Tags
- Finance (17 results)
- Nasdaq Stock Market Inc. (16 results)
- financial (8 results)
- SALES (6 results)
- SEC (5 results)
- Investment (5 results)
- Government (4 results)
- IVAX Corp. (4 results)
- Jim Edwards (4 results)
- adidas AG (4 results)
- MARKETING (4 results)
- Pharmaceutical Company (3 results)
- Shareholder (3 results)
- FDA (3 results)
- stock (3 results)
- Healthcare (3 results)
- Bentley Pharmaceuticals Inc. (3 results)
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
